We therefore studied LPL mass and activity, hepatic lipase activity, the levels of apolipoprotein C-II and apo E and apo A-V polymorphisms in order to detect any differences between persons with hypertriglyceridaemia who developed hypertriglyceridaemic pancreatitis and those who did not. The gene discussed is LPL; the disease is hypertriglyceridemia.